Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 18, Issue 6, 2013, Pages 560-569

  Song, Yunxiao ^a   Ge, Wen ^a   Cai, Haibing ^a   Zhang, Haichen ^a  

^a SHANGHAI XUHUI CENTRAL HOSPITAL   (China)

Author keywords

coxsackievirus; curcumin; myocarditis; NF B; PI3K Akt; proinflammatory cytokines

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE MB; CURCUMIN; I KAPPA B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; COXSACKIE VIRUS B3; CREATINE KINASE BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; HISTOPATHOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; VIRAL CLEARANCE; VIRUS MYOCARDITIS; WEIGHT REDUCTION;

COXSACKIEVIRUS; CURCUMIN; MYOCARDITIS; NF-ΚB; PI3K/AKT; PROINFLAMMATORY CYTOKINES;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COXSACKIEVIRUS INFECTIONS; CURCUMIN; CYTOKINES; INFLAMMATION; MALE; MICE; MICE, INBRED BALB C; MYOCARDITIS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887587867     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248413503044     Document Type: Article

References (40)

1. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation. 2001 ; 104 (9). 1076-8102
2. Calabrese F, Thiene G. Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res. 2003 ; 60 (1). 11-25
3. Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J. 2008 ; 29 (17). 2073-2082
4. Wiltshire SA, Leiva-Torres GA, Vidal SM. Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of Tnni3k, Fpgt, or H28 control susceptibility to viral myocarditis. J Immunol. 2011 ; 186 (11). 6398-6405
5. Gauntt C, Huber S. Coxsackievirus experimental heart diseases. Front Biosci. 2003 ; 8: e23 - e35
6. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000 ; 343 (19). 1388-1398
7. Henke A, Jarasch N, Wutzler P. Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis. Expert Rev Vaccines. 2008 ; 7 (10). 1557-1567
8. Yue Y, Gui J, Xu W, Xiong S. Gene therapy with CCL2 (MCP-1) mutant protects CVB3-induced myocarditis by compromising Th1 polarization. Mol Immunol. 2011 ; 48 (4). 706-713
9. Yue Y, Gui J, Ai W, Xu W, Xiong S. Direct gene transfer with IP-10 mutant ameliorates mouse CVB3-induced myocarditis by blunting Th1 immune responses. PLoS ONE. 2011 ; 6 (3). e18186
10. Ding Y, Qiu L, Zhao G, Xu J, Wang S. Influence of cinnamaldehyde on viral myocarditis in mice. Am J Med Sci. 2010 ; 340 (2). 114-120
11. Alter P, Rupp H, Maisch B. Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy - relation to inflammation and cardiac function. Biochem Biophys Res Commun. 2006 ; 339 (1). 180-187
12. Lee JY, Hwang DH. The modulation of inflammatory gene expression by lipids: mediation through toll-like receptors. Mol Cells. 2006 ; 21 (2). 174-185
13. Zhang H, Song Y, Zhang Z. Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice. Am J Med Sci. 2012 ; 344 (3). 206-210
14. Matsumori A, Nunokawa Y, Yamaki A, et al. Suppression of cytokines and nitric oxide production, and protection against lethal endotoxemia and viral myocarditis by a new NF-kappaB inhibitor. Eur J Heart Fail. 2004 ; 6 (2). 137-144
15. Gui J, Yue Y, Chen R, Xu W, Xiong S. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling. PLoS ONE. 2012 ; 7 (9). e46515
16. Hyam SR, Lee IA, Gu W, et al. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/Akt pathway and polarizing M1 macrophages to M2-like macrophages. Eur J Pharmacol. 2013 ; 708 (1-3). 21-29
17. Han W, Xiong Y, Li Y, et al. Anti-arthritic effects of clematichinenoside (AR-6) on PI3K/Akt signaling pathway and TNF-α associated with collagen-induced arthritis. Pharm Biol. 2013 ; 51 (1). 13-22
18. Venkatachalam K, Mummidi S, Cortez DM, Prabhu SD, Valente AJ, Chandrasekar B. Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2008 ; 294 (5). H2078 - H2087
19. Li XQ, Cao W, Li T, et al. Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int Immuno Pharmacol. 2009 ; 9 (9). 1032-1041
20. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med. 1991 ; 57 (1). 1-7
21. Shishodia S, Singh T, Chaturvedi MM. Modulation of transcription factors by curcumin. Adv Exp Med Biol. 2007 ; 595: 127-148
22. Shishodia S. Molecular mechanisms of curcumin action: gene expression. Biofactors. 2013 ; 39 (1). 37-55
23. Shehzad A, Lee YS. Molecular mechanisms of curcumin action: signal transduction. Biofactors. 2013 ; 39 (1). 27-36
24. Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999 ; 163 (6). 3474-3483
25. Bharti AC, Donato N, Singh S, Aggarwal BB. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 2003 ; 101 (3). 1053-1062
26. Larmonier CB, Midura-Kiela MT, Ramalingam R, et al. Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis. 2011 ; 17 (2). 503-515
27. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol. 2008 ; 75 (4). 787-809
28. Jagetia GC. Aggarwal BB. "Spicing up" of the immune system by curcumin. J Clin Immunol. 2007 ; 27 (1). 19-35
29. Kobelt G. Health economic issues in rheumatoid arthritis. Scand J Rheumatol. 2006 ; 35 (6). 415-425
30. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008 ; 14 (14). 4491-4499
31. Huber SA, Sartini D, Exley M. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J Virol. 2002 ; 76 (21). 10785-10790
32. Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res. 2011 ; 21 (2). 223-244
33. Woodruff JF. Viral myocarditis. a review. Am J Pathol. 1980 ; 101 (2). 425-484
34. Rezkalla S, Kloner RA, Khatib G, Khatib R. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis. Circulation. 1990 ; 81 (3). 1039-1046
35. Maier R, Krebs P, Ludewig B. Immunopathological basis of virus-induced myocarditis. Clin Dev Immunol. 2004 ; 11 (1). 1-5
36. Esfandiarei M, McManus BM. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol. 2008 ; 3: 127-155
37. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994 ; 72 (6). 561-566
38. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-d-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem. 2004 ; 279 (31). 32869-32881
39. Salminen A, Kaarniranta K. Insulin/IGF-1 paradox of aging: regulation via Akt/IKK/NF-kappaB signaling. Cell Signal. 2010 ; 22 (4). 573-577
40. Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation. 2009 ; 119 (19). 2615-2624